[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Fries et al., 2019 - Google Patents

Preliminary investigation of peripheral extracellular vesicles' microRNAs in bipolar disorder

Fries et al., 2019

Document ID
2895357971798300480
Author
Fries G
Lima C
Valvassori S
Zunta-Soares G
Soares J
Quevedo J
Publication year
Publication venue
Journal of Affective Disorders

External Links

Snippet

Background The search for biomarkers of bipolar disorder (BD), including epigenetic alterations, has heavily relied on peripheral investigations that do not necessarily reflect brain-specific mechanisms. In this study we aimed to assess peripheral extracellular …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
Fries et al. Preliminary investigation of peripheral extracellular vesicles’ microRNAs in bipolar disorder
Roy et al. Identification of microRNA-124-3p as a putative epigenetic signature of major depressive disorder
Fries et al. Accelerated hippocampal biological aging in bipolar disorder
Hadar et al. SIRT1, miR-132 and miR-212 link human longevity to Alzheimer’s Disease
Maffioletti et al. Peripheral whole blood microRNA alterations in major depression and bipolar disorder
Li et al. Alterations of serum levels of BDNF-related miRNAs in patients with depression
He et al. Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre-and post-treatment patients with major depressive disorder
Enatescu et al. Circulating plasma micro RNAs in patients with major depressive disorder treated with antidepressants: a pilot study
Smalheiser et al. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects
Bavamian et al. Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder
Schipper et al. MicroRNA expression in Alzheimer blood mononuclear cells
Elton et al. Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins
Chen et al. The inhibition of microRNA-128 on IGF-1-activating mTOR signaling involves in temozolomide-induced glioma cell apoptotic death
Hervé et al. Translational identification of transcriptional signatures of major depression and antidepressant response
Li et al. MicroRNA-101a regulates autophagy phenomenon via the MAPK pathway to modulate Alzheimer’s-associated pathogenesis
Belzeaux et al. Potential use of MicroRNA for monitoring therapeutic response to antidepressants
Li et al. Changes in microRNAs associated with podocytic adhesion damage under mechanical stress
Cruceanu et al. Synapsin II is involved in the molecular pathway of lithium treatment in bipolar disorder
Xu et al. MicroRNA-449c-5p inhibits osteogenic differentiation of human VICs through Smad4-mediated pathway
Luo et al. Effect of the autism‐associated lncRNA Shank2‐AS on architecture and growth of neurons
Christensen et al. Molecular profiling of the lateral habenula in a rat model of depression
Dwivedi microRNA-124: a putative therapeutic target and biomarker for major depression
Xiu et al. Elevated BICD2 DNA methylation in blood of major depressive disorder patients and reduction of depressive-like behaviors in hippocampal Bicd2-knockdown mice
Zhang et al. Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of Müller cells via Forkhead box protein O4
Menke Gene expression: biomarker of antidepressant therapy?